Transparency: Moon Mother sends each batch of product to a third-party lab to be tested for potency as well as other contaminants. You can find all of these lab reports on the company’s website. They also added more information about their company processes to the website, so it’s easier to find important information about extraction and manufacturing.
Vaping can be complicated, intimidating, and expensive, but with this brilliant Disposable Vape Pen with CBD from CBDfx, you can start vaping with ease. It comes pre-charged and pre-filled with a refreshing, minty e-liquid and has been designed with simplicity at its heart. Simply remove from the packaging and start vaping. Once you’re finished, throw it away!
Because our hemp oil products are categorized as dietary supplements in the United States, we comply with the FDA’s DSHEA guidelines and cannot endorse any specific medical benefits of CBD or our CBD oil. To further comply with FDA regulations, HempMeds® does not list a Recommended Daily Intake (RDI) of our own, nor do we provide a Daily Value (%DV) for any of our products. We encourage you to browse the thousands of reputable studies regarding CBD published online and talk with your doctor to see if a CBD oil supplement is right for you.

The amount of milligrams of CBD you should take depends on your specific reason for taking CBD. If you are using CBD to treat chronic pain, you might take a much higher dose than someone who would be using CBD for general wellness reasons. Google search for your specific condition or reason for taking CBD to find the dose that is appropriate for you. You can take CBD in high qualities, so feel free to test out different dosages and see how your body reacts. A standard dose of CBD is 10 mg once a day, but this varies so widely because each individual is different so this can’t be taken as a recommendation for you.


Generalized pain, for instance, has dozens upon dozens of high profile research and clinical studies that have been carried out in universities and laboratories around the globe. One of the most well-publicized of these studies took place back in 2008, in which results determined that “cannabinoid analgesics (pain relievers) have generally been well tolerated in clinical trials … with acceptable adverse event profiles (meaning acceptable effectiveness for practical use).
×